Dr Mai-Immunopathology Flashcards
What is Hypersensitivity?
When it happens?
- Excessive,undesirable reactions produced by the immune system.
- 2nd time
what is Immunodeficiency ?
-Defect in 1/more components of immune system
What are allergens?
-Is a substance that produces an allergic response
Immune complexes consist of
a. antibody plus complement
b. basophil plus complement
c. antigen plus antibody
d. antigen plus complement
c. antigen plus antibody
Blood transfusion hypersensitivity reactions are examples of:
a. Type IV hypersensitivity
b. Type III hypersensitivity
c. Type II hypersensitivity
d. Type I hypersensitivity
c. Type II hypersensitivity
A hypersensitivity reaction occurs
a. During the first exposure to an antigen
b. During a second or subsequent exposure to an antigen
c. In individuals with the disease of the immune system
d. none of above
b. During a second or subsequent exposure to an antigen
- A possitive tuberculin test is an example of what type of hypersensitivity reaction ?
a. Type IV hypersensitivity ( No memory B cells)
b. Type III hypersensitivity
c. Type II hypersensitivity
d. Type I hypersensitivity
a. Type IV hypersensitivity ( No memory B cells)
- What 2 isotypes of antibody can cause type II and type III hypersensitivity diseases?
IgM and IgG
- List name of 5 common allergens can cause the anaphylactic reaction?
- Atopic dermatitis (children)
- Milk allergy (Jersey cattle)
- Allergic inhalant dermatitis ( Terriers and Dalmatian dogs)
- Fever (human)
- Asthma (human)
- Why is desensitization therapy used in type I hypersensitivity ?
Because this therapy can :
-Reduce mediator release from Mast cells
-Decrease the number of Mast cells in tissues
-Decrease serum IgE levels on Mast cells and produce
blocking antibody IgG
- What is the result of the actions of mast cell mediators in anaphylaxis? (2marks)
Advances in mast cell signaling research have improved our understanding of the pathophysiology of anaphylaxis. The identification of signaling pathways and components that amplify signals or alter the threshold of activation of mast cells, leading to degranulation and mediator release, has the promise of identifying novel approaches for prevention and treatment of anaphylaxis. The discovery of polymorphisms and mutations in components that regulate mast cell signaling might lead to ways to identify subjects who are most susceptible to life-threatening episodes of anaphylaxis caused by mast cell activation
- What are the 2 main mechanisms causing injury in anti-tissue ( Type II hypersensitivity) disease? (2)
-Complement Activation
Recall that cross-linked antibodies normally activate the Classical Pathway of the Complement Cascade. This results in the generation of the membrane-disrupting “Membrane Attack Complex” or causes opsonization of the material with C3 which recruits other immune cells to phagocytose the opsonized material. When antibodies target host cells, complement activation can cause direct injury to the host cells as well as induce potent inflammation and phagocytic destruction of host tissue
-Antibody-mediated Cell-mediated Cytotoxicity (ADCC)
Once cross-linked onto antigen, the Fc Region of antibody normally recruits a number of phagocytic immune cells such as macrophages and neutrophils which are then activated to phagocytose the opsonized material. When antibodies target host membranes this can result in substantial inflammation and phagocytic destruction of host tissues.
- What is immunodeficiency ? What are the most common causes of immunodeficiency? (3)
- A genetic or acquired defect results in an inability to mount an immune response and thus control infections, resulting in severe systemic inflammation.
- Primary immunodeficiency: the result of a congenital or genetic defect in a component of the immune system. Although the defect may be present at birth, the disease may not be manifested until later in life
- What is the mechanism of Type II Antibody-Mediated Cytotoxic Disorders?
IgG or IgM antibodies bind to antigens on the cell surface and destroys or prevents the cell from functioning
- What are the specific ways the target cell is destroyed or disabled in Type II Antibody-Mediated Cytotoxic Disorders?
- Complement mediated lysis
- Phagocytosis
- Neutrophil mediated